Pvg Asset Management »

Anavex Life Sciences shares owned by Pvg Asset Management

Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Pvg Asset Management from 13F filings

Historical chart of Pvg Asset Management investment in Anavex Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences held by Pvg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences by Pvg Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.0M 111k 9.22
2025-03-31 $709k 83k 8.58
2024-12-31 $843k 79k 10.74
2024-09-30 $74k 13k 5.68

More positions owned by Pvg Asset Management

SPDR Barclays Capital 1-3 month Etf (BIL)
Vanguard Index S&P 500 Etf (VOO)
Journey Med Corp (DERM)
Anavex Life Sciences (AVXL)
S&p 500 Indx Etf (IVV)
Female Health (VERU)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Neos ETF Trust S&P 500 High Income Etf (SPYI)
Invesco ETF Tr S&P Equal Weighted Etf (RSP)
Grail (GRAL)
Fortress Biotech (FBIO)
ARK Innovation ETF Etf (ARKK)

View all positions for Pvg Asset Management

Top funds holding Anavex Life Sciences

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Susquehanna International
Two Sigma Investments
Nwam
Northern Trust
Two Sigma Advisers
Charles Schwab Investment Management
Citadel Advisors
Morgan Stanley
LPL Financial
UBS Group
Private Advisor

View all funds holding Anavex Life Sciences